> top > docs > PMC:7293470 > spans > 2345-2604 > annotations

PMC:7293470 / 2345-2604 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T79 23-27 CHEBI:23888;CHEBI:23888 denotes drug
T80 75-83 CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811 denotes platelet
T81 83-94 GO:0030168;CHEBI:44811;CHEBI:44811 denotes -activating
T82 95-101 CHEBI:44811;CHEBI:44811 denotes factor
T83 106-115 CHEBI:18295;CHEBI:18295 denotes histamine
T84 121-130 CL:0000097 denotes mast cell
T85 167-189 CHEBI:35472;CHEBI:35472 denotes anti-inflammatory drug
T86 221-232 CHEBI:26995;CHEBI:26995 denotes thromboxane
T70978 23-27 CHEBI:23888;CHEBI:23888 denotes drug
T2252 75-83 CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811 denotes platelet
T56269 83-94 GO:0030168;CHEBI:44811;CHEBI:44811 denotes -activating
T88762 95-101 CHEBI:44811;CHEBI:44811 denotes factor
T44552 106-115 CHEBI:18295;CHEBI:18295 denotes histamine
T96679 121-130 CL:0000097 denotes mast cell
T70624 167-189 CHEBI:35472;CHEBI:35472 denotes anti-inflammatory drug
T40591 221-232 CHEBI:26995;CHEBI:26995 denotes thromboxane

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T29 75-83 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T30 106-115 Body_part denotes histamine http://purl.org/sig/ont/fma/fma61806
T31 121-130 Body_part denotes mast cell http://purl.org/sig/ont/fma/fma66784
T32 126-130 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T46 84-94 http://purl.obolibrary.org/obo/CLO_0001658 denotes activating
T47 126-130 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T48 159-160 http://purl.obolibrary.org/obo/CLO_0001020 denotes A

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T30 23-27 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T31 75-101 Chemical denotes platelet-activating factor http://purl.obolibrary.org/obo/CHEBI_36707|http://purl.obolibrary.org/obo/CHEBI_44811|http://purl.obolibrary.org/obo/CHEBI_52450
T34 106-115 Chemical denotes histamine http://purl.obolibrary.org/obo/CHEBI_18295|http://purl.obolibrary.org/obo/CHEBI_58432
T36 167-189 Chemical denotes anti-inflammatory drug http://purl.obolibrary.org/obo/CHEBI_35472
T37 185-189 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T38 202-212 Chemical denotes antagonist http://purl.obolibrary.org/obo/CHEBI_48706
T39 221-232 Chemical denotes thromboxane http://purl.obolibrary.org/obo/CHEBI_26995
T40 246-255 Chemical denotes cysteinyl http://purl.obolibrary.org/obo/CHEBI_23511|http://purl.obolibrary.org/obo/CHEBI_32460

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T9 75-94 http://purl.obolibrary.org/obo/GO_0030168 denotes platelet-activating
T10 131-140 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T12 2-158 Sentence denotes Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamine, and mast cell secretion-blocking effects.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
133 106-115 Chemical denotes histamine MESH:D006632